Pediatric non-alcoholic fatty liver disease: An increasing public health issue

European Journal of Pediatrics

Volumn 173, Issue 2, 2014, Pages 131-139

  Berardis, S ^a   Sokal, E ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Liver fibrosis; Non alcoholic fatty liver disease; Pediatric patients; Steatohepatitis

Indexed keywords

ALPHA TOCOPHEROL; FARNESOID X RECEPTOR; INCRETIN; METFORMIN; PENTOXIFYLLINE; POLYUNSATURATED FATTY ACID; PROBIOTIC AGENT; TOLL LIKE RECEPTOR; URSODEOXYCHOLIC ACID;

BALLOONING; BARIATRIC SURGERY; CHILDHOOD DISEASE; CLINICAL FEATURE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIET; DRUG TARGETING; ECHOGRAPH; ECHOGRAPHY; GOLD STANDARD; HEPATITIS; HISTOPATHOLOGY; HUMAN; LIFESTYLE MODIFICATION; LIVER BIOPSY; LIVER DISEASE; LIVER FIBROSIS; NONALCOHOLIC FATTY LIVER; PATHOGENESIS; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCORING SYSTEM;

ADOLESCENT; BIOPSY; CHILD; COMBINED MODALITY THERAPY; DIET, REDUCING; DISEASE PROGRESSION; DRUGS, INVESTIGATIONAL; END STAGE LIVER DISEASE; FATTY LIVER; FEMALE; HUMANS; LIFE STYLE; LIVER; LIVER CIRRHOSIS; MALE; OBESITY; OVERWEIGHT; RISK FACTORS; ULTRASONOGRAPHY;

EID: 84897584454     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-013-2157-6     Document Type: Review

References (73)

1. Abdelmalek MF, Suzuki A, Guy C, Unalp-Arida A, Colvin R, Johnson RJ, Diehl AM (2010) Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 51:1961-1971
2. Alisi A, Bedogni G, De VR, Comparcola D, Manco M, Nobili V (2011) Relationship between portal chronic inflammation and disease severity in paediatric non-alcoholic fatty liver disease. Dig Liver Dis 43:143-146
3. Alisi A, Feldstein AE, Villani A, Raponi M, Nobili V (2012) Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach. Nat Rev Gastroenterol Hepatol 9:152-161
4. Alisi A, Manco M, Vania A, Nobili V (2009) Pediatric nonalcoholic fatty liver disease in 2009. J Pediatr 155:469-474
5. Alisi A, Nobili V (2011) Nonalcoholic fatty liver disease: targeted therapy in children - what is the right way? Nat Rev Gastroenterol Hepatol 8:425-426
6. Alkhouri N, Carter-Kent C, Lopez R, Rosenberg WM, Pinzani M, Bedogni G, Feldstein AE, Nobili V (2011) A combination of the pediatric NAFLD fibrosis index and enhanced liver fibrosis test identifies children with fibrosis. Clin Gastroenterol Hepatol 9:150-155
7. Alkhouri N, De VR, Alisi A, Yerian L, Lopez R, Feldstein AE, Nobili V (2012) Development and validation of a new histological score for pediatric non-alcoholic fatty liver disease. J Hepatol 57:1312-1318
8. Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346:1221-1231
9. Brunt EM (2010) Pathology of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 7:195-203
10. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94:2467-2474
11. Brunt EM, Tiniakos DG (2010) Histopathology of nonalcoholic fatty liver disease. World J Gastroenterol 16:5286-5296
12. Burt AD, Mutton A, Day CP (1998) Diagnosis and interpretation of steatosis and steatohepatitis. Semin Diagn Pathol 15:246-258
13. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57:1470-1481
14. Carter-Kent C, Yerian LM, Brunt EM, Angulo P, Kohli R, Ling SC, Xanthakos SA, Whitington PF, Charatcharoenwitthaya P, Yap J, Lopez R, McCullough AJ, Feldstein AE (2009) Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study. Hepatology 50:1113-1120
15. Day CP (2011) Non-alcoholic fatty liver disease: a massive problem. Clin Med 11:176-178
16. Deboer MD (2011) Ethnicity, obesity and the metabolic syndrome: implications on assessing risk and targeting intervention. Expert Rev Endocrinol Metab 6:279-289
17. Della CC, Alisi A, Saccari A, De VR, Vania A, Nobili V (2012) Nonalcoholic fatty liver in children and adolescents: an overview. J Adolesc Health 51:305-312
18. Esposito E, Iacono A, Bianco G, Autore G, Cuzzocrea S, Vajro P, Canani RB, Calignano A, Raso GM, Meli R (2009) Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats. J Nutr 139:905-911
19. Feldstein AE, Nobili V (2010) Biomarkers in nonalcoholic fatty liver disease: a new era in diagnosis and staging of disease in children. J Pediatr Gastroenterol Nutr 51:378-379
20. Fitzpatrick E, Mitry RR, Quaglia A, Hussain MJ, DeBruyne R, Dhawan A (2010) Serum levels of CK18 M30 and leptin are useful predictors of steatohepatitis and fibrosis in paediatric NAFLD. J Pediatr Gastroenterol Nutr 51:500-506
21. Fraser A, Longnecker MP, Lawlor DA (2007) Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004. Gastroenterology 133:1814-1820
22. Frasinariu OE, Ceccarelli S, Alisi A, Moraru E, Nobili V (2012) Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: an input for novel therapies. Dig Liver Dis 45(7):543-551
23. Fuchs M (2012) Non-alcoholic Fatty liver disease: the bile Acid-activated farnesoid X receptor as an emerging treatment target. J Lipids 2012:934396
24. Kechagias S, Ernersson A, Dahlqvist O, Lundberg P, Lindstrom T, Nystrom FH (2008) Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects. Gut 57:649-654
25. Kleiner DE, Brunt EM, Van NM, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313-1321
26. Ko JS, Yoon JM, Yang HR, Myung JK, Kim H, Kang GH, Cheon JE, Seo JK (2009) Clinical and histological features of nonalcoholic fatty liver disease in children. Dig Dis Sci 54:2225-2230
27. Koot BG, van der Baan-Slootweg OH, Tamminga-Smeulders CL, Rijcken TH, Korevaar JC, van Aalderen WM, Jansen PL, Benninga MA (2011) Lifestyle intervention for non-alcoholic fatty liver disease: prospective cohort study of its efficacy and factors related to improvement. Arch Dis Child 96:669-674
28. Lavine JE, Schwimmer JB, Van Natta ML, Molleston JP, Murray KF, Rosenthal P, Abrams SH, Scheimann AO, Sanyal AJ, Chalasani N, Tonascia J, Unalp A, Clark JM, Brunt EM, Kleiner DE, Hoofnagle JH, Robuck PR (2011) Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA 305:1659-1668
29. Lee J, Hong SW, Rhee EJ, Lee WY (2012) GLP-1 receptor agonist and non-alcoholic fatty liver disease. Diabetes Metab J 36:262-267
30. Li W, Zheng L, Sheng C, Cheng X, Qing L, Qu S (2011) Systematic review on the treatment of pentoxifylline in patients with non-alcoholic fatty liver disease. Lipids Health Dis 10:49
31. Loguercio C, Federico A, Tuccillo C, Terracciano F, D'Auria MV, De SC, Del Vecchio BC (2005) Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases. J Clin Gastroenterol 39:540-543
32. Ludwig J, Viggiano TR, McGill DB, Oh BJ (1980) Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55:434-438
33. Manco M, Alisi A, Nobili V (2008) Risk of severe liver disease in NAFLD with normal ALT levels: a pediatric report. Hepatology 48:2087-2088
34. Marra F, Gastaldelli A, Svegliati BG, Tell G, Tiribelli C (2008) Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol Med 14:72-81
35. Masterton GS, Plevris JN, Hayes PC (2010) Review article: omega-3 fatty acids - a promising novel therapy for non-alcoholic fatty liver disease. Aliment Pharmacol Ther 31:679-692
36. Mencin AA, Lavine JE (2011) Nonalcoholic fatty liver disease in children. Curr Opin Clin Nutr Metab Care 14:151-157
37. Miura K, Seki E, Ohnishi H, Brenner DA (2010) Role of toll-like receptors and their downstream molecules in the development of nonalcoholic fatty liver disease. Gastroenterol Res Pract 2010:362847
38. Moran JR, Ghishan FK, Halter SA, Greene HL (1983) Steatohepatitis in obese children: a cause of chronic liver dysfunction. Am J Gastroenterol 78:374-377
39. Nadeau KJ, Ehlers LB, Zeitler PS, Love-Osborne K (2009) Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents. Pediatr Diabetes 10:5-13
40. Nobili V, Alisi A, Della CC, Rise P, Galli C, Agostoni C, Bedogni G (2012) Docosahexaenoic acid for the treatment of fatty liver: randomised controlled trial in children. Nutr Metab Cardiovasc Dis. doi: 10.1016/j.numecd.2012.10.010
41. Nobili V, Alisi A, Vania A, Tiribelli C, Pietrobattista A, Bedogni G (2009) The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease. BMC Med 7:21
42. Nobili V, Bedogni G, Alisi A, Pietrobattista A, Rise P, Galli C, Agostoni C (2011) Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial. Arch Dis Child 96:350-353
43. Nobili V, Carpino G, Alisi A, Franchitto A, Alpini G, De VR, Onori P, Alvaro D, Gaudio E (2012) Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease. Hepatology 56:2142-2153
44. Nobili V, Manco M, Ciampalini P, Alisi A, Devito R, Bugianesi E, Marcellini M, Marchesini G (2008) Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study. Clin Ther 30:1168-1176
45. Nobili V, Manco M, Devito R, Di C, V, Comparcola D, Sartorelli MR, Piemonte F, Marcellini M, Angulo P (2008) Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology 48:119-128
46. Nobili V, Marcellini M, Devito R, Ciampalini P, Piemonte F, Comparcola D, Sartorelli MR, Angulo P (2006) NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice. Hepatology 44:458-465
47. Nobili V, Monti L, Alisi A, Lo ZC, Pietrobattista A, Toma P (2011) Transient elastography for assessment of fibrosis in paediatric liver disease. Pediatr Radiol 41:1232-1238
48. Nobili V, Svegliati-Baroni G, Alisi A, Miele L, Valenti L, Vajro P (2012) A 360-degree overview of paediatric NAFLD: recent insights. J Hepatol 58(6):1218-1229
49. Nobili V, Vizzutti F, Arena U, Abraldes JG, Marra F, Pietrobattista A, Fruhwirth R, Marcellini M, Pinzani M (2008) Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology 48:442-448
50. Pacifico L, Nobili V, Anania C, Verdecchia P, Chiesa C (2011) Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk. World J Gastroenterol 17:3082-3091
51. Patel DA, Srinivasan SR, Chen W, Berenson GS (2011) Serum alanine aminotransferase and its association with metabolic syndrome in children: the bogalusa heart study. Metab Syndr Relat Disord 9:211-216
52. Perseghin G (2010) The role of non-alcoholic fatty liver disease in cardiovascular disease. Dig Dis 28:210-213
53. Qayyum A, Chen DM, Breiman RS, Westphalen AC, Yeh BM, Jones KD, Lu Y, Coakley FV, Callen PW (2009) Evaluation of diffuse liver steatosis by ultrasound, computed tomography, and magnetic resonance imaging: which modality is best? Clin Imaging 33:110-115
54. Reinehr T, Schmidt C, Toschke AM, Andler W (2009) Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study. Arch Dis Child 94:437-442
55. Roberts EA (2007) Pediatric nonalcoholic fatty liver disease (NAFLD): a "growing" problem? J Hepatol 46:1133-1142
56. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, Mullen KD, Cooper JN, Sheridan MJ (2002) The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123:745-750
57. Samuel VT, Liu ZX, Qu X, Elder BD, Bilz S, Befroy D, Romanelli AJ, Shulman GI (2004) Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 279:32345-32353
58. Schwimmer JB, Behling C, Newbury R, Deutsch R, Nievergelt C, Schork NJ, Lavine JE (2005) Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology 42:641-649
59. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C (2006) Prevalence of fatty liver in children and adolescents. Pediatrics 118:1388-1393
60. Schwimmer JB, Middleton MS, Deutsch R, Lavine JE (2005) A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis. Aliment Pharmacol Ther 21:871-879
61. Schwimmer JB, Pardee PE, Lavine JE, Blumkin AK, Cook S (2008) Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. Circulation 118:277-283
62. Shannon A, Alkhouri N, Carter-Kent C, Monti L, Devito R, Lopez R, Feldstein AE, Nobili V (2011) Ultrasonographic quantitative estimation of hepatic steatosis in children With NAFLD. J Pediatr Gastroenterol Nutr 53:190-195
63. Swiderska-Syn M, Suzuki A, Guy CD, Schwimmer JB, Abdelmalek MF, Lavine JE, Diehl AM (2013) Hedgehog pathway and pediatric nonalcoholic fatty liver disease. Hepatology 57:1814-1825
64. Tiniakos DG, Vos MB, Brunt EM (2010) Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol 5:145-171
65. Vajro P, Franzese A, Valerio G, Iannucci MP, Aragione N (2000) Lack of efficacy of ursodeoxycholic acid for the treatment of liver abnormalities in obese children. J Pediatr 136:739-743
66. Vajro P, Lenta S, Socha P, Dhawan A, McKiernan P, Baumann U, Durmaz O, Lacaille F, McLin V, Nobili V (2012) Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr 54:700-713
67. Vajro P, Mandato C, Franzese A, Ciccimarra E, Lucariello S, Savoia M, Capuano G, Migliaro F (2004) Vitamin E treatment in pediatric obesity-related liver disease: a randomized study. J Pediatr Gastroenterol Nutr 38:48-55
68. Vajro P, Mandato C, Licenziati MR, Franzese A, Vitale DF, Lenta S, Caropreso M, Vallone G, Meli R (2011) Effects of Lactobacillus rhamnosus strain GG in pediatric obesity-related liver disease. J Pediatr Gastroenterol Nutr 52:740-743
69. Wang CL, Liang L, Fu JF, Zou CC, Hong F, Xue JZ, Lu JR, Wu XM (2008) Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children. World J Gastroenterol 14:1598-1602
70. Weiner RA (2010) Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease. Dig Dis 28:274-279
71. Widhalm K, Ghods E (2010) Nonalcoholic fatty liver disease: a challenge for pediatricians. Int J Obes (Lond) 34:1451-1467
72. Xanthakos S, Miles L, Bucuvalas J, Daniels S, Garcia V, Inge T (2006) Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents. Clin Gastroenterol Hepatol 4:226-232
73. Zelman S (1952) The liver in obesity. AMA Arch Intern Med 90:141-156